Trial intelligence / Profile preview

Autophagy inhibition in standard-therapy-resistant HCV patients

IRCT2013121515805N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of chloroquine in hepatitis C virus infection, sponsored by Shiraz University of Medical Sciences. Started Mar 2014; status: completed.

02

Drugs

chloroquine
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on IRCT2013121515805N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013121515805N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call